Regulators In Japan Cut Away At New Drug Review Time
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Japan is posting an overall improvement in shortening the average time it takes regulators to review new drugs, according to a government evaluation committee that rated the operational performance of the Pharmaceuticals and Medical Devices Agency
You may also be interested in...
Japanese Health Ministry To Ask Drug Makers To Submit Applications For 100-plus Pharmaceutical Products; Vows Quick Review Process
TOKYO - In an unusual move aimed at solving part of Japan's drug lag problem, the Ministry of Health, Labor and Welfare is set to ask pharmaceutical makers to submit applications to market a total of 109 drugs that have already been approved in other countries, an MHLW official said May 10
Japanese Health Ministry To Ask Drug Makers To Submit Applications For 100-plus Pharmaceutical Products; Vows Quick Review Process
TOKYO - In an unusual move aimed at solving part of Japan's drug lag problem, the Ministry of Health, Labor and Welfare is set to ask pharmaceutical makers to submit applications to market a total of 109 drugs that have already been approved in other countries, an MHLW official said May 10
Tokyo Aims To Speed Up Drug Approvals, Catch Up With U.S., Says Japanese Health Ministry Official
TOKYO - Japan is in the process of aligning itself with global pharmaceutical standards, according to Shuichi Kishida, councilor for pharmaceutical safety at the Ministry of Health, Labor and Welfare